Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
5.46
-0.24 (-4.21%)
Apr 27, 2026, 4:00 PM EDT - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $9.85 million as of April 28, 2026. Its market cap has increased by 143.01% in one year.
Market Cap
9.85M
Enterprise Value
-6.57M
1-Year Change
143.01%
Ranking
Category
Stock Price
$5.46
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $9.85M, a decrease of -89.86%. That is a compound annual growth rate of -39.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 9.85M | -18.66% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 11.36M |
| BioVie | 11.31M |
| CytoMed Therapeutics | 11.25M |
| Lunai Bioworks | 11.25M |
| Imunon | 10.94M |
| Aprea Therapeutics | 10.65M |
| Kiora Pharmaceuticals | 10.31M |
| Enveric Biosciences | 10.01M |